You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mPDAC

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RWE on mPDAC Long-term Survival After Treatment With Liposomal

Recruiting
  • Pancreatic Cancer Metastatic
    • Munich, Germany
      Klinikum der Universität München, - Anstalt des öffentlichen Rec
    Nov 24, 2023

    Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,

    Not yet recruiting
    • Pancreatic Cancer
    • TTX-030, nab-paclitaxel and gemcitabine
    • +2 more
    • (no location specified)
    Nov 3, 2023

    Pancreatic Cancer Trial in Munich, Heidelberg, Zürich (SBRT, SOC chemo)

    Recruiting
    • Pancreatic Cancer
    • SBRT
    • SOC chemotherapy
    • Munich, Bavaria, Germany
    • +2 more
    Apr 6, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Worldwide (NIS793, Nab-paclitaxel, Gemcitabine)

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Fayetteville, Arkansas
    • +122 more
    Jan 27, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Spain, United States (Palbociclib, Nab-Paclitaxel)

    Completed
    Has Results
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Scottsdale, Arizona
    • +25 more
    Mar 10, 2021

    Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +3 more
    • Cholesterol metabolism disruption
    • Quebec city, Quebec, Canada
      CHU de Québec-Université Laval
    Oct 17, 2022

    Metastatic Pancreatic Adenocarcinoma Trial in United States (Nivolumab (Cohort A), Ipilimumab (Cohort A and B),

    Active, not recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Nivolumab (Cohort A)
    • +4 more
    • Los Angeles, California
    • +6 more
    Aug 8, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in United States (Relacorilant, 100 mg and 25 mg, Nab paclitaxel)

    Terminated
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Relacorilant, 100 mg and 25 mg
    • Nab paclitaxel
    • Scottsdale, Arizona
    • +17 more
    May 11, 2022

    Tolerability of Liposomal Irinotecan

    Active, not recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Onivyde® + 5-FULV
    • Edegem, Belgium
      Antwerp University Hosptital
    Jan 31, 2022

    Locally Advanced or Metastatic Solid Tumours Trial in Worldwide (AZD0171, Durvalumab, Gemcitabine)

    Recruiting
    • Locally Advanced or Metastatic Solid Tumours
    • Scottsdale, Arizona
    • +46 more
    Jun 13, 2022

    Phase II, Open-label, Parallel 2-arm, Multi-center Trial in Kaohsiung, Taichung, Tainan (Gemcitabine 1000 mg, Nab paclitaxel,

    Recruiting
    • Phase II, Open-label, Parallel 2-arm, Multi-center
    • Gemcitabine 1000 mg
    • +4 more
    • Kaohsiung, Taiwan
    • +2 more
    Jun 12, 2022

    Adenocarcinoma of the Pancreas Trial in Italy, Spain (Valproic acid, Simvastatin 20mg, Gemcitabine 1000 mg)

    Not yet recruiting
    • Adenocarcinoma of the Pancreas
    • Valproic acid
    • +4 more
    • Milano, Italy
    • +4 more
    Apr 6, 2023

    Response to Antineoplastic Treatment of Metastatic Cancer

    Recruiting
    • Metastatic Cancer
    • blood sample collection
    • Linz, Upper Austria, Austria
      Ordensklinikum Linz
    Mar 9, 2021

    Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,

    Not yet recruiting
    • Pancreatic Cancer Metastatic
    • Colorectal Cancer Metastatic
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Aug 5, 2022

    Pancreatic Adenocarcinoma Trial in Verona (Irinotecan Liposomal Injection [Onivyde]; oxaliplatin, 5-FU; Levofolinic Acid)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Irinotecan Liposomal Injection [Onivyde]; oxaliplatin, 5-FU; Levofolinic Acid
    • Verona, Italy
      Centro Ricerche Cliniche
    Jul 27, 2021

    Disseminated Pancreatic Cancer Trial in Linköping (Liver resection (ablation))

    Not yet recruiting
    • Disseminated Pancreatic Cancer
    • Liver resection (ablation)
    • Linköping, Sweden
      Linkoping University Hospital
    Feb 26, 2022